In a preliminary study, we identified differentially expressed genes (DEGs) in liver samples of patients with MASH such as interleukin-32 (IL-32) and chemokine CC ligand 20 (CCL20), which are associated with fibrogenesis and MASLD. The gene discussed is IL32; the disease is metabolic dysfunction-associated steatotic liver disease.